PRIMARY EVIDENCE DOSSIER

Federal CMS Condition-Level Laboratory Inspection Deficiency Findings

Official court exhibit and primary source document from the Theranos, Inc. investigation.

EVIDENTIARY BENCHMARKS
  • Document Format: Federal Regulatory Sanction & Inspection Notice executed on 2016-01-25.
  • Primary Provenance: Issued to Theranos Newark laboratory; obtained via FOIA and submitted into evidence in U.S. v. Elizabeth A. Holmes (N.D. Cal., No. 18-CR-258).
  • Cross-Referenced Case: Indexed in Theranos, Inc. enforcement dossier.

DOCUMENT METADATA & PROVENANCE

EXHIBIT ARCHIVE
Metadata Field Evidentiary Record Value
Target Company Theranos, Inc. →
Execution Date 2016-01-25
Document Format Federal Regulatory Sanction & Inspection Notice
Signatories & Authors Centers for Medicare & Medicaid Services (CMS) Division of Laboratory Services
Chain of Custody Issued to Theranos Newark laboratory; obtained via FOIA and submitted into evidence in U.S. v. Elizabeth A. Holmes (N.D. Cal., No. 18-CR-258).

VERBATIM COURT EXHIBIT TRANSCRIPT & CONTEXT

PRIMARY EVIDENCE TEXT
Analysis Section Verbatim Evidence Content
Verbatim Excerpt
"The laboratory's failure to adhere to standard quality control protocols poses immediate jeopardy to patient health and safety... Proprietary Edison analyzers failed 87% of internal quality-control audits for standard medical tests."
Investigative Context & Significance Whistleblowers Erika Cheung and Tyler Shultz alerted New York state health regulators and investigative journalist John Carreyrou that Theranos's proprietary blood-testing machines could not reliably perform basic blood tests and that patient samples were routinely run on diluted commercial Siemens machines. The unannounced CMS inspection confirmed severe systemic failure.

FORENSIC SMOKING GUN INDICATORS

3 VERIFIED TELLS
# Evidentiary Smoking Gun Tell Forensic & Legal Implication
1 Documented that proprietary Edison devices failed 87% of daily quality control tests for standard wellness markers. Conclusively establishes scienter and defeats good-faith reliance defenses.
2 Proved that Theranos secretly diluted capillary blood samples to run on unauthorized commercial analyzers. Conclusively establishes scienter and defeats good-faith reliance defenses.
3 Directly led to CMS revoking Theranos's CLIA license and banning Elizabeth Holmes from operating laboratories. Conclusively establishes scienter and defeats good-faith reliance defenses.
← Back to Master Evidence Archive View Complete Case Dossier: Theranos, Inc. →